This company has been acquired
Tabula Rasa HealthCare Future Growth
Future criteria checks 1/6
Tabula Rasa HealthCare is forecast to grow earnings and revenue by 77.5% and 13.2% per annum respectively while EPS is expected to grow by 78.7% per annum.
Key information
77.5%
Earnings growth rate
78.7%
EPS growth rate
| Healthcare Services earnings growth | 31.8% |
| Revenue growth rate | 13.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Sep 2023 |
Recent future growth updates
Recent updates
Continuing To Avoid Tabula Rasa HealthCare Inc.
May 19Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?
May 11
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Feb 09Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)
Jan 19Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching
Dec 06Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?
Nov 05Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price
Jul 26Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Jun 28We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed
Jun 05Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price
Apr 02Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt
Mar 12Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years
Feb 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 469 | -8 | N/A | N/A | 1 |
| 12/31/2024 | 416 | -15 | N/A | N/A | 4 |
| 12/31/2023 | 362 | -31 | N/A | N/A | 4 |
| 6/30/2023 | 338 | -61 | -24 | -5 | N/A |
| 3/31/2023 | 321 | -64 | -9 | 14 | N/A |
| 12/31/2022 | 300 | -77 | -21 | 7 | N/A |
| 9/30/2022 | 286 | -72 | -14 | 22 | N/A |
| 6/30/2022 | 277 | -58 | -15 | 23 | N/A |
| 3/31/2022 | 268 | -59 | -34 | 4 | N/A |
| 12/31/2021 | 260 | -52 | -20 | 15 | N/A |
| 9/30/2021 | 268 | -70 | -27 | 2 | N/A |
| 6/30/2021 | 271 | -80 | -24 | 2 | N/A |
| 3/31/2021 | 283 | -80 | -22 | 2 | N/A |
| 12/31/2020 | 221 | -57 | -17 | 5 | N/A |
| 9/30/2020 | 293 | -57 | -16 | 6 | N/A |
| 6/30/2020 | 297 | -44 | -10 | 13 | N/A |
| 3/31/2020 | 297 | -36 | -4 | 20 | N/A |
| 12/31/2019 | 285 | -32 | -29 | -6 | N/A |
| 9/30/2019 | 269 | -36 | -20 | 0 | N/A |
| 6/30/2019 | 249 | -18 | -20 | -4 | N/A |
| 3/31/2019 | 221 | -40 | -23 | -11 | N/A |
| 12/31/2018 | 204 | -47 | 5 | 16 | N/A |
| 9/30/2018 | 190 | -26 | 7 | 16 | N/A |
| 6/30/2018 | 169 | -30 | 7 | 15 | N/A |
| 3/31/2018 | 149 | -3 | 9 | 17 | N/A |
| 12/31/2017 | 133 | 13 | 12 | 18 | N/A |
| 9/30/2017 | 117 | -3 | 10 | 16 | N/A |
| 6/30/2017 | 109 | -8 | 1 | 7 | N/A |
| 3/31/2017 | 102 | -7 | N/A | 4 | N/A |
| 12/31/2016 | 95 | -3 | N/A | 7 | N/A |
| 9/30/2016 | 87 | 4 | N/A | 3 | N/A |
| 6/30/2016 | 80 | -11 | N/A | 9 | N/A |
| 3/31/2016 | 75 | -12 | N/A | 7 | N/A |
| 12/31/2015 | 70 | -13 | N/A | 3 | N/A |
| 9/30/2015 | 64 | -20 | N/A | 3 | N/A |
| 6/30/2015 | 59 | -6 | N/A | 3 | N/A |
| 3/31/2015 | 53 | -5 | N/A | 3 | N/A |
| 12/31/2014 | 48 | -5 | N/A | 1 | N/A |
| 12/31/2013 | 25 | -9 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TRHC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TRHC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TRHC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TRHC's revenue (13.2% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: TRHC's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TRHC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/04 08:01 |
| End of Day Share Price | 2023/11/02 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tabula Rasa HealthCare, Inc. is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| William Sutherland | Benchmark Company |
| Steven Halper | Cantor Fitzgerald & Co. |